PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9177459-0	1997	Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice.	Dehydroepiandrosterone	11-33	B cell leukemia/lymphoma 2	Mus musculus	65-70	
9177459-0	1997	Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice.	Dehydroepiandrosterone	11-33	BCL2-associated X protein	Mus musculus	71-74	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	99-121	B cell leukemia/lymphoma 2	Mus musculus	54-59	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	99-121	BCL2-associated X protein	Mus musculus	67-70	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	99-121	transformation related protein 53, pseudogene	Mus musculus	212-215	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	99-121	transformation related protein 53, pseudogene	Mus musculus	227-230	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	123-127	B cell leukemia/lymphoma 2	Mus musculus	54-59	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	123-127	BCL2-associated X protein	Mus musculus	67-70	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	123-127	transformation related protein 53, pseudogene	Mus musculus	212-215	
9177459-1	1997	Modulation of apoptosis through altered expression of Bcl-2 and/or Bax may be a mechanism by which dehydroepiandrosterone (DHEA) administration and calorie restriction (CR) exert their chemopreventive effects in p53-deficient (p53-/-) mice.	Dehydroepiandrosterone	123-127	transformation related protein 53, pseudogene	Mus musculus	227-230	
9177459-7	1997	Treatment of p53-/- animals with DHEA resulted in decreased Bcl-2 but not Bax mRNA levels in the thymus.	Dehydroepiandrosterone	33-37	transformation related protein 53, pseudogene	Mus musculus	13-16	
9177459-7	1997	Treatment of p53-/- animals with DHEA resulted in decreased Bcl-2 but not Bax mRNA levels in the thymus.	Dehydroepiandrosterone	33-37	B cell leukemia/lymphoma 2	Mus musculus	60-65